IMARC Group, a leading market research company, has recently releases report titled “Stem Cell Manufacturing Market Report by Product (Consumables, Instruments, Stem Cell Lines), Application (Research Applications, Clinical Application, Cell and Tissue Banking Applications), End User (Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories and Contract Research Organizations, Hospitals and Surgical Centers, Cell and Tissue banks, and Others), and Region 2024-2032”,  Offers a comprehensive analysis of the industry, which comprises insights on the global stem cell manufacturing market.

How Big Is the Stem Cell Manufacturing Market?

The global stem cell manufacturing market size reached US$ 13.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032.

Industry Overview of Stem Cell Manufacturing

Stem cell manufacturing refers to the controlled, scalable, and reproducible production of stem cells in a laboratory setting for various medical applications. It involves the production of embryonic stem cells, mesenchymal stem cells, hematopoietic stem cells, and induced pluripotent stem cells. It enables the development of groundbreaking treatments and therapies for previously incurable diseases and injuries. It reduces dependence on scarce donor sources, such as bone marrow or organ transplants. It accelerates scientific research by providing a consistent and reproducible source of cells for studying disease mechanisms and drug development. It facilitates faster and more accurate drug development, leading to safer and more effective medications.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/stem-cell-manufacturing-market/requestsample

What are the growth prospects and trends in the stem cell manufacturing industry?

At present, the increasing demand for stem cells for treating conditions like heart disease, spinal cord injuries, and degenerative disorders, such as Parkinson’s and Alzheimer’s disease, represents one of the crucial factors impelling the growth of the market.

Besides this, the rising utilization of stem cells to create disease models for drug testing, reducing the practice of animal testing, and accelerating the drug development process are contributing to the growth of the market.

In addition, the growing employment of stem-cell-derived tissues and organs for toxicology studies, allowing researchers to assess the safety of new drugs and chemicals more accurately, is offering a favorable market outlook. Apart from this, the increasing demand for regenerative medicine and cell-based therapies is supporting the growth of the market.

Leading Companies Operating in the Global Stem Cell Manufacturing Industry:

• Anterogen Co. Ltd.
• Becton Dickinson and Company
• Bio-Rad Laboratories Inc.
• Bio-Techne Corporation
• Corning Incorporated
• FUJIFILM Holdings Corporation
• Lonza Group AG
• Merck KGaA
• Sartorius AG
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

Stem Cell Manufacturing Market Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

• Consumables
  • Culture Media
  • Others
• Instruments
  • Bioreactors and Incubators
  • Cell Sorters
  • Others
• Stem Cell Lines
  • Hematopoietic Stem Cells (HSC)
  • Mesenchymal Stem Cells (MSC)
  • Induced Pluripotent Stem Cells (iPSC)
  • Embryonic Stem Cells (ESC)
  • Neural Stem Cells (NSC)
  • Multipotent Adult Progenitor Stem Cells

Breakup by Application:

• Research Applications
  • Life Science Research
  • Drug Discovery and Development
• Clinical Application
  • Allogenic Stem Cell Therapy
  • Autologous Stem Cell Therapy
• Cell and Tissue Banking Applications

Breakup by End User:

• Pharmaceutical & Biotechnology Companies
• Academic Institutes, Research Laboratories and Contract Research Organizations
• Hospitals and Surgical Centers
• Cell and Tissue banks
• Others

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163